Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Calgary

$25,000.00

Probing the biochemistry of toxic metals in the bloodstream

FY 2013-14

Summary
Human activities, such as fossil fuel consumption and mining activities emit quantities of toxic metals that rival or exceed natural global emissions and they are projected to increase (e.g. coal consumption will increase by 1/5th over the next 25 years). This will be associated with an increased influx of inorganic pollutants into the human bloodstream. Despite much research, there exist considerable knowledge gaps with regard to our understanding of the biochemistry of toxic metals in the bloodstream. A better understanding of these processes, however, is urgently needed to establish the biochemical mechanisms which may link the exposure of humans - including children - to toxic metals with diseases and to develop strategies to efflux toxic metals from the body. The visualization of biochemical events that occur in the bloodstream, however, poses a major problem. Dr. Gailer's group has developed a methodology which allows to analyze blood plasma for proteins which contain a bound metal (e.g. iron, copper or zinc) and are therefore referred to as plasma metalloproteins. Since this methodology can simultaneously detect any toxic metals that are added to plasma, we can gain fundamentally new insight into biochemical processes by which toxic metals may adversely effect the metabolism of essential metals. In addition, it allows to study the effect of drugs (so-called chelating agents) which can be administered to intoxicated humans to increase the mobilization of a toxic metal from the body. The developed methodology will be systematically applied to probe the effect of toxic metals in plasma at the metalloprotein level and to study the efficacy of chelating agents. Novel metal-containing metabolites will be structurally characterized using an advanced spectroscopic technique (Canadian Light Source, Saskatoon). This approach is expected to provide exciting new insights into the toxicology of environmentally abundant toxic metals and metalloid compounds and is the prerequisite for the development of remedies against the chronic toxicity of metal/metalloids in humans. The proposed research thus represents an initiative to advance human health in the 21st century.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
313041-2013
Name nom
Gailer, Juergen
Department département
Chemistry
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
406
Area of application group en
Environment
Area of application group fr
Environnement
Area of application en
Pollutants and toxic agents (waste, use 902)
Area of application fr
Polluants et agents toxiques (déchets, utiliser 902)
Research subject code
6403
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Toxicology
Research subject fr
Toxicologie
Partie
1
Nb partie
1
Application title
Probing the biochemistry of toxic metals in the bloodstream
Keyword
NSERC
Application summary
Human activities, such as fossil fuel consumption and mining activities emit quantities of toxic metals that rival or exceed natural global emissions and they are projected to increase (e.g. coal consumption will increase by 1/5th over the next 25 years). This will be associated with an increased influx of inorganic pollutants into the human bloodstream. Despite much research, there exist considerable knowledge gaps with regard to our understanding of the biochemistry of toxic metals in the bloodstream. A better understanding of these processes, however, is urgently needed to establish the biochemical mechanisms which may link the exposure of humans - including children - to toxic metals with diseases and to develop strategies to efflux toxic metals from the body. The visualization of biochemical events that occur in the bloodstream, however, poses a major problem. Dr. Gailer's group has developed a methodology which allows to analyze blood plasma for proteins which contain a bound metal (e.g. iron, copper or zinc) and are therefore referred to as plasma metalloproteins. Since this methodology can simultaneously detect any toxic metals that are added to plasma, we can gain fundamentally new insight into biochemical processes by which toxic metals may adversely effect the metabolism of essential metals. In addition, it allows to study the effect of drugs (so-called chelating agents) which can be administered to intoxicated humans to increase the mobilization of a toxic metal from the body. The developed methodology will be systematically applied to probe the effect of toxic metals in plasma at the metalloprotein level and to study the efficacy of chelating agents. Novel metal-containing metabolites will be structurally characterized using an advanced spectroscopic technique (Canadian Light Source, Saskatoon). This approach is expected to provide exciting new insights into the toxicology of environmentally abundant toxic metals and metalloid compounds and is the prerequisite for the development of remedies against the chronic toxicity of metal/metalloids in humans. The proposed research thus represents an initiative to advance human health in the 21st century.